Terconazole gel for vaginal infection

Phase 3, randomised, double-blind trial in vulvovaginal candidiasis (VVC) comparing Terconazole vaginal gel with Gel vehicle (2 arms). Primary endpoint: Clinical Cure as Assessed by the Investigator at the Test-of-cure Visit. Started Jun 2015; status: completed.